New weekly shot hopes to tame genetic obesity
NCT ID NCT06239116
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 25 times
Summary
This study tests a new weekly injection called RM-718 in people with obesity, including those with a genetic condition affecting the MC4R pathway (like Prader-Willi syndrome). The main goal is to check the drug's safety and how the body processes it. About 150 participants will take part in this early-stage research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ann and Robert H. Lurie Children's Hospital of Chicago (Part C and Part D)
RECRUITINGChicago, Illinois, 60611, United States
-
Boston Children's Hospital (Part C only)
RECRUITINGBoston, Massachusetts, 021115, United States
-
Brigham and Women's Hospital (Part C and Part D)
RECRUITINGBoston, Massachusetts, 02115, United States
-
UAB Pediatric Endocrinology (Part C and Part D)
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of Utah Pediatric Endocrine Clinic (Part C and Part D)
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Vanderbilt University Medical Center (Part C only)
RECRUITINGNashville, Tennessee, 37232, United States
-
Worldwide Clinical Trials (Part A and Part B)
COMPLETEDSan Antonio, Texas, 78217, United States
Conditions
Explore the condition pages connected to this study.